These previously reported results clearly confirmed the detrimental effects of the Kyn-AHR pathway in acute stroke and, more importantly, the post-stroke responsiveness of the brain AHR pathway to peripherally-sourced molecules (Kyn or pharmacological inhibitors18). The gene discussed is AHR; the disease is stroke disorder.